Article

Case report highlights rationale for neovascular glaucoma treatment

Denver-Intravitreal bevacizumab (Avastin, Genentech) proved to be a successful treatment in a patient with neovascular glaucoma.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
Related Content
(Image credit: AdobeStock/Anton Gvozdikov)
April 22nd 2025

When the world went virtual: How ophthalmology’s conferences stayed on track

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Researchers develop virus-like particle to enhance editing proteins causing inherited eye diseases
April 22nd 2025

Researchers develop virus-like particle to enhance editing proteins causing inherited eye diseases

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Prevent Blindness urges West Virginia State Legislature to reject bill removing newborn eye infection protection
April 21st 2025

Prevent Blindness urges West Virginia State Legislature to reject bill removing newborn eye infection protection

Unveiling genetic distinctions between reticular pseudodrusen and drusen
April 21st 2025

Unveiling genetic distinctions between reticular pseudodrusen and drusen

© 2025 MJH Life Sciences

All rights reserved.